MedTrace Logo

The Feasibility of Pertussis Immunization in a Canadian Emergency Department

NCT03304275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 644

Last updated 2018-01-26

No results posted yet for this study

Summary

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine to patients presenting to the emergency department. Rates of vaccination as well as effects on department efficiency will be measured.

Conditions

  • Pertussis

Interventions

BEHAVIORAL

Tdap

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine

Sponsors & Collaborators

  • The Queen Elizabeth Hospital

    collaborator OTHER

  • University of Prince Edward Island

    lead OTHER

Principal Investigators

  • Aaron Sibley, MD · University of Prince Edward Island

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-10
Primary Completion
2017-12-20
Completion
2017-12-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03304275 on ClinicalTrials.gov